BrainCo files for Hong Kong IPO after raising $287M for non-invasive BCI and bionic limbs
Summary
BrainCo, a neurotechnology company developing non-invasive brain-computer interfaces and bionic limbs, has filed for a Hong Kong IPO after raising $287 million (2 billion yuan) earlier in 2025. The Hangzhou-based company is one of China's leading BCI firms, with products spanning intelligent prosthetics, neurofeedback training systems, and brain-controlled devices for education and rehabilitation.
Why it matters
BrainCo's planned Hong Kong IPO represents a significant milestone for China's neurotechnology sector, potentially becoming one of the first major BCI companies to go public in Asia. The company's non-invasive approach to BCI technology makes it more accessible for consumer and educational applications, while its prosthetic limb products address a critical need for affordable, brain-controlled artificial limbs.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial